Nivaa, Denmark

Are Bogsnes

This inventor holds 5 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Novo Nordisk A/s, Novo Nordisk Healthcare Ag. Active years: 2001-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Are Bogsnes. Retrieved from https://idiyas.com/inventor/are-bogsnes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Nivå, DK (2001 - 2015)
  • Nivaa, DK (2014 - 2016)

Company Filing History:


Years Active: 2001-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Are Bogsnes

Introduction: Are Bogsnes is a male inventor hailing from Nivå, Denmark, known for his innovative contributions to various fields.

Latest Patents: Are Bogsnes holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced materials science.

Career Highlights: Throughout his career, Are Bogsnes has been recognized for his groundbreaking work in developing eco-friendly solutions for everyday challenges. His inventions have significantly impacted the way industries approach sustainability.

Collaborations: Are Bogsnes has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of innovation.

Conclusion: Are Bogsnes continues to be a driving force in the world of inventions, consistently pushing the envelope to create a more sustainable and efficient future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…